ARCHIVES

Atlas Showing County Cancer Rates Available

This article is from The Cancer Letter archive.

Vol. 01 No. 29 | July 18, 1975

Download PDF Visit The Full Archive

Related Articles

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

FDA Advisors Okay NCI Toxicology Proposals, Write New Clinical Guidelines, Approve AIN DA

October 19, 1979

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

MD Anderson Completes $500 Million Research Endowment

September 24, 2010

President’s Cancer Panel urges comprehensive health care reform, provision of services for cancer survivors.

June 4, 2004

First Lady Helps Dedicate New MDA Facilities

October 15, 1976